Monthly Archives: February 2008

From Fuel to Food to Fashion

Industrial biotech does it all. The Third Wave in biotech is looking bright for the future. Industrial biotech represents the confluence of market demand and the potential for market solution, according to David Berry, MD, PhD of Flagship Ventures – one of the panel speakers. Synthetic biotechnology, for one, is enabling the next generation in biofuels, while companies like Mascoma are commercializing cellulosic ethanol.  The future vision for industrial biotech is to have a significant and Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Mind the Gap: Pharma Chasing Biotech Assets

Validation with big pharma – is it still necessary? Depends on who you talk to. This was one of several questions posed to panelists at today’s business roundtable session. Arguments can be made on both sides, but one thing is for certain, the life sciences financing community has become much more sophisticated in recent years. And biotech and pharma companies have become more sophisticated in doing deals because they have a lot more experience to Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Sen. Brownback to speak at Global Health conference

Global health is the spotlight as BIO teams up with BIO Ventures for Global Health (BVGH) and the Gates Foundation to host the first Partnering for Global Health conference in Washington, D.C.  Kansas Senator Sam Brownback will be a key speaker. This brand new, international event will focus on opportunities for the biotech industry to help accelerate the development of medicines for neglected diseases of the developing world. More info is at http://pgh.bio.org/opencms/PGH/2008/index.jsp  

Events  |  Leave a comment  |  Email This Post
Tags:

The Weather Outside is Frightful

The biggest buzz aside from biotech at the CEO conference is definitely the light snowfall outside.  Word on the street is that it will continue to warm up and the snow won’t stick, hopefully no one’s travel will be dramatically inconvenienced tomorrow. If you want a second opinion: www.weather.com

Business of Biotech  |  Leave a comment  |  Email This Post
Tags:

Our Very Own Jim Greenwood on CNBC

Check it out: http://www.cnbc.com/id/15840232?video=647792797

Corporate  |  Leave a comment  |  Email This Post
Tags: